High Cholesterol

A research team has developed a new approach to prescribing statins which would lower the risk of heart attack for many people. Millions of people...

Higher concentrations of low-density lipoprotein (LDL) that has been modified by oxidation is associated with an increased incidence of abdominal obesity, high fasting glucose levels and high triglyceride levels and the metabolic syndrome, which includes a combination of these conditions.

What's bad for your ticker may be good for your bean, according to research from a team of scientists at Boston University.

Statin Study group cites nearly 900 studies on the adverse effects of HMG-CoA reductase inhibitors (statins), a class of drugs widely used to treat high cholesterol.

Researchers found a greater risk of heart attack associated with Vioxx than Celebrex.

Report suggests that aggressively pursuing low blood pressure and cholesterol levels may not benefit, and could even harm, some patients with diabetes.

Scientists in Japan have shown that this waste product of rice processing, called rice bran, significantly lowers blood pressure in rats whose hypertension resembles that of humans.

A comparison of two types of medications to treat type 2 diabetes finds that pioglitazone is more effective at lowering the rate of progression of plaque build-up in the coronary arteries than glimepiride, according to a study in the April 2 issue of JAMA.

Aggressively lowering cholesterol and blood pressure levels below current targets in adults with type 2 diabetes may help to prevent - and possibly reverse - hardening of the arteries.

Having a high level of HDL cholesterol – the good cholesterol – is more important than having a low level of LDL – the bad cholesterol.

The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new study in the April 2 issue of JAMA.

Colesevelam hydrochloride appears to be an effective lipid-lowering agent that significantly reduces low-density lipoprotein (LDL) cholesterol levels, according to a study published in the October issue of Mayo Clinic Proceedings.

A new study led by researchers at Joslin Diabetes Center has identified insulin resistance in the liver as a key factor in the cause of metabolic syndrome and its associated atherosclerosis.

Women often miss out on cholesterol screening and nutrition counseling because their physicians do a poor job of following the recommended guidelines for cardiovascular care in women, according to a recent study.

NCEP suggests that people at risk for heart attack and stroke would benefit from more intensive cholesterol-lowering therapies.

Lifestyle changes between childhood and adulthood appear associated with whether an individual will maintain, improve or develop high-risk cholesterol levels.